Voices
Drew Moghanaki
Drew Moghanaki/LinkedIn

Drew Moghanaki: Compelling Global Evidence Drives the Powerful Rise of SBRT in Early-Stage NSCLC

Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared a post on LinkedIn:

“As our group at UCLA recently demonstrated from an NCDB dataset, a multidisciplinary team in the Netherlands reports similarly increasing utilization of SBRT for early-stage NSCLC in their country.”

Drew Moghanaki

Title: Impact of COVID-19 pandemic on treatment patterns for stage I Non-Small Cell Lung Cancer in the Netherlands

Authors: R. M. G. van Vuren, N. Wolfhagen, R. A. M. Damhuis, S. Kruijff, W. Y. van der Plas, W. H. Schreurs, O. C. J. Schuurbiers, H. J. M. Smit, A. F. T. M. Verhagen, M. W. Wouters, J. Belderbos, D. J. Heineman

Read The Full Article

Drew Moghanaki

More posts featuring Drew Moghanaki on OncoDaily.

A. F. T. M. Verhagen cancer D. J. Heineman Drew Moghanaki H. J. M. Smit J. Belderbos M. W. Wouters N. Wolfhagen O. C. J. Schuurbiers OncoDaily Oncology R. A. M. Damhuis R. M. G. van Vuren S. Kruijff W. H. Schreurs W. Y. van der Plas